Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depression, Postpartum | 20 | 2024 | 355 | 9.940 |
Why?
|
Cervical Length Measurement | 14 | 2022 | 47 | 6.500 |
Why?
|
Premature Birth | 24 | 2023 | 1830 | 5.190 |
Why?
|
Perinatal Care | 14 | 2024 | 246 | 4.740 |
Why?
|
Pregnancy | 160 | 2024 | 30265 | 4.230 |
Why?
|
Cervix Uteri | 13 | 2022 | 577 | 3.940 |
Why?
|
Pregnancy Complications | 20 | 2024 | 2974 | 3.240 |
Why?
|
Postpartum Period | 21 | 2024 | 1198 | 2.850 |
Why?
|
Pregnancy Complications, Infectious | 19 | 2024 | 2190 | 2.810 |
Why?
|
Cesarean Section | 16 | 2024 | 1426 | 2.770 |
Why?
|
Depression | 26 | 2024 | 8231 | 2.590 |
Why?
|
Cerclage, Cervical | 6 | 2020 | 32 | 2.570 |
Why?
|
Pregnancy Trimester, Second | 11 | 2022 | 736 | 2.390 |
Why?
|
Obstetrics | 8 | 2023 | 682 | 2.190 |
Why?
|
Hypertension, Pregnancy-Induced | 5 | 2024 | 529 | 2.060 |
Why?
|
Prenatal Care | 16 | 2024 | 1162 | 2.050 |
Why?
|
Vaginal Birth after Cesarean | 4 | 2021 | 65 | 2.050 |
Why?
|
Illinois | 17 | 2024 | 120 | 1.930 |
Why?
|
Extraction, Obstetrical | 3 | 2021 | 28 | 1.910 |
Why?
|
Obstetric Labor Complications | 5 | 2021 | 244 | 1.910 |
Why?
|
Pregnant Women | 11 | 2024 | 576 | 1.870 |
Why?
|
Delivery, Obstetric | 12 | 2023 | 955 | 1.810 |
Why?
|
Depressive Disorder | 7 | 2023 | 3723 | 1.550 |
Why?
|
Pregnancy Outcome | 17 | 2023 | 2974 | 1.530 |
Why?
|
Anxiety | 14 | 2024 | 4672 | 1.510 |
Why?
|
Obstetric Labor, Premature | 4 | 2020 | 268 | 1.500 |
Why?
|
Postpartum Hemorrhage | 5 | 2019 | 275 | 1.490 |
Why?
|
Infectious Disease Transmission, Vertical | 11 | 2024 | 1360 | 1.480 |
Why?
|
Female | 186 | 2024 | 397515 | 1.470 |
Why?
|
Infant, Newborn | 42 | 2024 | 26428 | 1.300 |
Why?
|
Obsessive-Compulsive Disorder | 4 | 2024 | 1508 | 1.200 |
Why?
|
Parity | 10 | 2023 | 931 | 1.150 |
Why?
|
Retrospective Studies | 69 | 2024 | 81903 | 1.140 |
Why?
|
Estrogen Antagonists | 2 | 2019 | 150 | 1.130 |
Why?
|
Fetal Blood | 3 | 2021 | 1361 | 1.130 |
Why?
|
Trial of Labor | 4 | 2021 | 85 | 1.110 |
Why?
|
Humans | 211 | 2024 | 768970 | 1.100 |
Why?
|
Vacuum Extraction, Obstetrical | 3 | 2021 | 14 | 1.100 |
Why?
|
Uterine Cervical Incompetence | 4 | 2020 | 24 | 1.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 6 | 2023 | 2276 | 1.080 |
Why?
|
Labor, Induced | 4 | 2023 | 156 | 1.070 |
Why?
|
Cefazolin | 3 | 2020 | 95 | 1.060 |
Why?
|
Indomethacin | 3 | 2020 | 323 | 1.060 |
Why?
|
Breast Feeding | 4 | 2024 | 1364 | 1.050 |
Why?
|
Placenta Diseases | 4 | 2017 | 199 | 1.050 |
Why?
|
HIV Infections | 17 | 2024 | 17591 | 1.040 |
Why?
|
Consciousness Disorders | 3 | 2017 | 445 | 1.030 |
Why?
|
Methadone | 2 | 2019 | 317 | 1.020 |
Why?
|
Stillbirth | 4 | 2022 | 381 | 1.020 |
Why?
|
Gynecology | 2 | 2022 | 534 | 1.010 |
Why?
|
Version, Fetal | 3 | 2021 | 22 | 0.990 |
Why?
|
Adult | 99 | 2024 | 223851 | 0.990 |
Why?
|
Breech Presentation | 3 | 2021 | 40 | 0.980 |
Why?
|
Emergency Medicine | 6 | 2019 | 1223 | 0.980 |
Why?
|
Educational Measurement | 4 | 2017 | 1260 | 0.950 |
Why?
|
Contraception | 6 | 2024 | 362 | 0.930 |
Why?
|
Diabetes, Gestational | 3 | 2022 | 1263 | 0.920 |
Why?
|
Ultrasonography, Prenatal | 6 | 2022 | 1771 | 0.910 |
Why?
|
Lacerations | 3 | 2021 | 150 | 0.890 |
Why?
|
Magnesium Sulfate | 2 | 2021 | 73 | 0.840 |
Why?
|
Asymptomatic Infections | 2 | 2021 | 136 | 0.830 |
Why?
|
Truth Disclosure | 2 | 2018 | 433 | 0.830 |
Why?
|
Mass Screening | 9 | 2019 | 5457 | 0.820 |
Why?
|
Obstetrical Forceps | 3 | 2021 | 9 | 0.820 |
Why?
|
Pre-Eclampsia | 4 | 2023 | 1255 | 0.810 |
Why?
|
Pregnancy Trimester, Third | 7 | 2023 | 586 | 0.810 |
Why?
|
Clinical Clerkship | 5 | 2017 | 569 | 0.790 |
Why?
|
Oligohydramnios | 1 | 2022 | 37 | 0.790 |
Why?
|
Polyhydramnios | 1 | 2022 | 41 | 0.780 |
Why?
|
Cohort Studies | 32 | 2024 | 41808 | 0.780 |
Why?
|
Fetal Membranes, Premature Rupture | 2 | 2021 | 137 | 0.780 |
Why?
|
Sexual Partners | 5 | 2021 | 807 | 0.780 |
Why?
|
Chest Pain | 3 | 2017 | 1101 | 0.770 |
Why?
|
Fever | 6 | 2017 | 1619 | 0.770 |
Why?
|
Uterine Artery Embolization | 3 | 2016 | 62 | 0.760 |
Why?
|
Infant, Newborn, Diseases | 3 | 2022 | 587 | 0.740 |
Why?
|
Multivariate Analysis | 15 | 2019 | 12095 | 0.740 |
Why?
|
Quality-Adjusted Life Years | 4 | 2024 | 1741 | 0.740 |
Why?
|
Depressive Disorder, Major | 4 | 2024 | 4818 | 0.740 |
Why?
|
Peer Review | 2 | 2024 | 219 | 0.710 |
Why?
|
Infant, Small for Gestational Age | 4 | 2022 | 468 | 0.710 |
Why?
|
Contraceptive Agents, Female | 1 | 2021 | 123 | 0.700 |
Why?
|
Hydroxyprogesterones | 2 | 2019 | 26 | 0.680 |
Why?
|
Postnatal Care | 2 | 2021 | 273 | 0.680 |
Why?
|
Congenital Abnormalities | 2 | 2022 | 704 | 0.660 |
Why?
|
Myometrium | 2 | 2017 | 174 | 0.660 |
Why?
|
Mental Health | 7 | 2024 | 3275 | 0.650 |
Why?
|
Placenta | 6 | 2021 | 1725 | 0.640 |
Why?
|
Hypokalemia | 2 | 2017 | 152 | 0.640 |
Why?
|
Dystocia | 2 | 2016 | 36 | 0.630 |
Why?
|
Uterine Balloon Tamponade | 2 | 2016 | 37 | 0.620 |
Why?
|
Viremia | 2 | 2022 | 725 | 0.620 |
Why?
|
Anal Canal | 1 | 2021 | 376 | 0.600 |
Why?
|
Decision Support Techniques | 7 | 2021 | 2008 | 0.600 |
Why?
|
Hydromorphone | 1 | 2018 | 70 | 0.600 |
Why?
|
Cost-Benefit Analysis | 7 | 2024 | 5544 | 0.580 |
Why?
|
Amphetamines | 1 | 2018 | 142 | 0.580 |
Why?
|
Gestational Age | 9 | 2022 | 3621 | 0.580 |
Why?
|
Babesiosis | 2 | 2017 | 92 | 0.580 |
Why?
|
Child Development | 3 | 2024 | 2336 | 0.580 |
Why?
|
Hyperglycemic Hyperosmolar Nonketotic Coma | 1 | 2017 | 30 | 0.580 |
Why?
|
Suture Techniques | 3 | 2018 | 779 | 0.580 |
Why?
|
Logistic Models | 13 | 2019 | 13318 | 0.570 |
Why?
|
Twins, Dizygotic | 1 | 2018 | 236 | 0.570 |
Why?
|
Muscle Weakness | 2 | 2019 | 413 | 0.560 |
Why?
|
Progestins | 1 | 2019 | 302 | 0.560 |
Why?
|
Diagnosis, Differential | 16 | 2024 | 13021 | 0.550 |
Why?
|
Psychotropic Drugs | 2 | 2022 | 881 | 0.540 |
Why?
|
Umbilical Cord | 1 | 2018 | 179 | 0.540 |
Why?
|
Young Adult | 31 | 2024 | 60131 | 0.540 |
Why?
|
Uterine Inertia | 1 | 2016 | 29 | 0.530 |
Why?
|
Directive Counseling | 2 | 2016 | 171 | 0.530 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 1 | 2016 | 94 | 0.520 |
Why?
|
Vaccination | 5 | 2024 | 3438 | 0.520 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 472 | 0.520 |
Why?
|
Jaundice | 1 | 2016 | 95 | 0.520 |
Why?
|
Dizziness | 2 | 2016 | 269 | 0.520 |
Why?
|
Torsades de Pointes | 1 | 2017 | 78 | 0.520 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 384 | 0.520 |
Why?
|
Pregnancy, Prolonged | 1 | 2015 | 9 | 0.520 |
Why?
|
Chicago | 3 | 2021 | 255 | 0.510 |
Why?
|
Balloon Occlusion | 1 | 2016 | 131 | 0.510 |
Why?
|
E2F4 Transcription Factor | 2 | 2017 | 33 | 0.500 |
Why?
|
Diphenhydramine | 1 | 2015 | 63 | 0.500 |
Why?
|
Uterine Cervical Dysplasia | 2 | 2019 | 392 | 0.500 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2016 | 65 | 0.500 |
Why?
|
Esophageal Perforation | 1 | 2015 | 65 | 0.490 |
Why?
|
Electrosurgery | 1 | 2015 | 53 | 0.490 |
Why?
|
Acidosis | 1 | 2017 | 271 | 0.490 |
Why?
|
Obsessive Behavior | 1 | 2015 | 51 | 0.490 |
Why?
|
Education, Medical, Undergraduate | 4 | 2017 | 1085 | 0.490 |
Why?
|
Medication Adherence | 2 | 2018 | 2192 | 0.490 |
Why?
|
Opiate Substitution Treatment | 1 | 2019 | 452 | 0.490 |
Why?
|
Cesarean Section, Repeat | 1 | 2015 | 32 | 0.480 |
Why?
|
Mediastinal Diseases | 1 | 2015 | 91 | 0.480 |
Why?
|
Narcotics | 1 | 2017 | 332 | 0.480 |
Why?
|
Anti-Obesity Agents | 1 | 2018 | 240 | 0.470 |
Why?
|
Twins | 1 | 2016 | 341 | 0.470 |
Why?
|
Infarction | 1 | 2016 | 247 | 0.470 |
Why?
|
Intubation, Gastrointestinal | 1 | 2015 | 166 | 0.470 |
Why?
|
Hyperthyroidism | 1 | 2016 | 292 | 0.460 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2016 | 239 | 0.460 |
Why?
|
Spinal Cord Compression | 1 | 2016 | 234 | 0.450 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 551 | 0.450 |
Why?
|
Malaria, Cerebral | 1 | 2015 | 136 | 0.440 |
Why?
|
Gait Disorders, Neurologic | 1 | 2016 | 243 | 0.440 |
Why?
|
Parents | 3 | 2024 | 3597 | 0.440 |
Why?
|
Watchful Waiting | 1 | 2018 | 498 | 0.440 |
Why?
|
Fibronectins | 1 | 2017 | 724 | 0.440 |
Why?
|
Pregnancy in Diabetics | 1 | 2015 | 198 | 0.440 |
Why?
|
Prospective Studies | 19 | 2024 | 54962 | 0.430 |
Why?
|
Risk Factors | 23 | 2024 | 74976 | 0.430 |
Why?
|
Risk Assessment | 10 | 2021 | 24333 | 0.420 |
Why?
|
Vomiting | 2 | 2017 | 655 | 0.420 |
Why?
|
Confusion | 1 | 2015 | 278 | 0.420 |
Why?
|
Antibodies, Viral | 3 | 2023 | 3215 | 0.420 |
Why?
|
Spinal Puncture | 3 | 2017 | 286 | 0.420 |
Why?
|
Risk | 6 | 2021 | 9621 | 0.420 |
Why?
|
Hypothyroidism | 2 | 2024 | 667 | 0.410 |
Why?
|
Personality Assessment | 1 | 2014 | 646 | 0.410 |
Why?
|
Perineum | 1 | 2014 | 212 | 0.410 |
Why?
|
Telemedicine | 3 | 2024 | 3110 | 0.400 |
Why?
|
Birth Injuries | 1 | 2014 | 151 | 0.400 |
Why?
|
Secondary Prevention | 1 | 2018 | 1476 | 0.400 |
Why?
|
Long QT Syndrome | 1 | 2017 | 472 | 0.400 |
Why?
|
Enterocolitis, Necrotizing | 1 | 2016 | 327 | 0.400 |
Why?
|
Emergency Service, Hospital | 11 | 2017 | 7957 | 0.390 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2018 | 783 | 0.390 |
Why?
|
Pandemics | 7 | 2023 | 8749 | 0.390 |
Why?
|
Anti-HIV Agents | 2 | 2018 | 4576 | 0.390 |
Why?
|
Medical History Taking | 2 | 2017 | 779 | 0.390 |
Why?
|
Intestinal Obstruction | 1 | 2015 | 433 | 0.390 |
Why?
|
Anti-Bacterial Agents | 7 | 2020 | 7478 | 0.390 |
Why?
|
Fetal Diseases | 1 | 2017 | 916 | 0.380 |
Why?
|
Autopsy | 1 | 2015 | 1013 | 0.380 |
Why?
|
Buprenorphine | 1 | 2019 | 667 | 0.380 |
Why?
|
Abortifacient Agents, Nonsteroidal | 1 | 2012 | 65 | 0.380 |
Why?
|
Puerperal Disorders | 2 | 2024 | 304 | 0.380 |
Why?
|
Suicidal Ideation | 1 | 2021 | 1462 | 0.370 |
Why?
|
Birth Intervals | 1 | 2011 | 55 | 0.370 |
Why?
|
Treatment Failure | 4 | 2019 | 2664 | 0.360 |
Why?
|
HIV | 1 | 2018 | 1597 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2017 | 775 | 0.360 |
Why?
|
Hypnotics and Sedatives | 2 | 2016 | 1191 | 0.360 |
Why?
|
Influenza, Human | 1 | 2022 | 1542 | 0.360 |
Why?
|
Myxedema | 1 | 2010 | 18 | 0.360 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2019 | 6030 | 0.360 |
Why?
|
Pregnancy, Ectopic | 1 | 2012 | 145 | 0.350 |
Why?
|
Status Epilepticus | 1 | 2016 | 463 | 0.350 |
Why?
|
Contraception Behavior | 4 | 2024 | 187 | 0.350 |
Why?
|
Procainamide | 1 | 2010 | 56 | 0.350 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2021 | 862 | 0.350 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3859 | 0.350 |
Why?
|
Prenatal Diagnosis | 1 | 2017 | 1275 | 0.350 |
Why?
|
Hypertension | 5 | 2024 | 8617 | 0.340 |
Why?
|
Pharyngeal Diseases | 1 | 2011 | 134 | 0.340 |
Why?
|
Fetus | 1 | 2017 | 1882 | 0.340 |
Why?
|
Attitude to Health | 1 | 2018 | 2025 | 0.340 |
Why?
|
Neck Pain | 1 | 2011 | 191 | 0.330 |
Why?
|
Patient Acceptance of Health Care | 2 | 2024 | 3235 | 0.320 |
Why?
|
Travel | 1 | 2015 | 805 | 0.320 |
Why?
|
United States | 22 | 2024 | 73186 | 0.310 |
Why?
|
Oxytocics | 2 | 2023 | 67 | 0.310 |
Why?
|
Low Back Pain | 1 | 2017 | 990 | 0.310 |
Why?
|
Subarachnoid Hemorrhage | 2 | 2014 | 1039 | 0.310 |
Why?
|
Inflammation | 2 | 2018 | 10868 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3118 | 0.310 |
Why?
|
Hydrogen-Ion Concentration | 3 | 2018 | 2488 | 0.300 |
Why?
|
Amiodarone | 1 | 2010 | 217 | 0.300 |
Why?
|
Tendinopathy | 1 | 2011 | 174 | 0.300 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3241 | 0.300 |
Why?
|
Thyroid Diseases | 1 | 2011 | 385 | 0.300 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3421 | 0.290 |
Why?
|
Abdominal Pain | 5 | 2019 | 1070 | 0.290 |
Why?
|
Hysterectomy | 4 | 2016 | 866 | 0.290 |
Why?
|
Mental Health Services | 3 | 2024 | 1732 | 0.290 |
Why?
|
Parturition | 2 | 2024 | 456 | 0.290 |
Why?
|
Birth Weight | 4 | 2022 | 2121 | 0.290 |
Why?
|
Mental Disorders | 3 | 2023 | 6876 | 0.290 |
Why?
|
Child | 16 | 2023 | 80960 | 0.280 |
Why?
|
Male | 39 | 2024 | 365203 | 0.280 |
Why?
|
Anemia | 1 | 2016 | 1517 | 0.270 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4356 | 0.270 |
Why?
|
Mianserin | 2 | 2017 | 51 | 0.270 |
Why?
|
Tricuspid Valve | 1 | 2010 | 419 | 0.270 |
Why?
|
Apgar Score | 4 | 2021 | 126 | 0.270 |
Why?
|
Hospitalization | 2 | 2024 | 10847 | 0.270 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2021 | 4056 | 0.260 |
Why?
|
Electrocardiography | 7 | 2017 | 6413 | 0.260 |
Why?
|
Predictive Value of Tests | 7 | 2021 | 15471 | 0.260 |
Why?
|
Heart Neoplasms | 1 | 2010 | 374 | 0.260 |
Why?
|
Osteogenesis | 2 | 2010 | 1295 | 0.260 |
Why?
|
Emergency Treatment | 1 | 2010 | 497 | 0.260 |
Why?
|
ROC Curve | 4 | 2021 | 3629 | 0.250 |
Why?
|
Skull | 1 | 2010 | 830 | 0.250 |
Why?
|
Maternal Age | 2 | 2021 | 805 | 0.250 |
Why?
|
Bipolar Disorder | 1 | 2022 | 5131 | 0.250 |
Why?
|
Students, Medical | 2 | 2017 | 1964 | 0.250 |
Why?
|
Anxiety Disorders | 3 | 2023 | 2749 | 0.240 |
Why?
|
Sex Factors | 2 | 2018 | 10633 | 0.240 |
Why?
|
Embryo, Mammalian | 2 | 2010 | 1676 | 0.240 |
Why?
|
Methotrexate | 1 | 2012 | 1723 | 0.240 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2339 | 0.240 |
Why?
|
Patient Participation | 1 | 2014 | 1448 | 0.240 |
Why?
|
Myocardial Ischemia | 1 | 2015 | 2139 | 0.240 |
Why?
|
Physicians | 2 | 2024 | 4607 | 0.240 |
Why?
|
Cause of Death | 1 | 2015 | 3721 | 0.240 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2022 | 2542 | 0.230 |
Why?
|
Ceftriaxone | 2 | 2016 | 175 | 0.230 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.230 |
Why?
|
Blood Pressure | 1 | 2020 | 8544 | 0.230 |
Why?
|
Case-Control Studies | 8 | 2021 | 22296 | 0.230 |
Why?
|
Sensitivity and Specificity | 6 | 2017 | 14752 | 0.220 |
Why?
|
Headache | 3 | 2017 | 1264 | 0.220 |
Why?
|
Narcotic Antagonists | 2 | 2019 | 591 | 0.220 |
Why?
|
Peripartum Period | 2 | 2023 | 137 | 0.220 |
Why?
|
Cytokines | 1 | 2018 | 7453 | 0.220 |
Why?
|
Intelligence Tests | 1 | 2024 | 505 | 0.210 |
Why?
|
Single-Blind Method | 2 | 2022 | 1586 | 0.210 |
Why?
|
Thrombosis | 1 | 2017 | 2956 | 0.210 |
Why?
|
Qualitative Research | 3 | 2024 | 3143 | 0.210 |
Why?
|
Clinical Protocols | 3 | 2019 | 1445 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6547 | 0.210 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 252 | 0.200 |
Why?
|
Contraceptive Agents | 1 | 2024 | 148 | 0.200 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5892 | 0.200 |
Why?
|
Vancomycin | 2 | 2016 | 506 | 0.200 |
Why?
|
Calcinosis | 1 | 2011 | 1479 | 0.200 |
Why?
|
Statistics, Nonparametric | 2 | 2018 | 2862 | 0.200 |
Why?
|
Registries | 2 | 2017 | 8384 | 0.200 |
Why?
|
Psychopharmacology | 1 | 2023 | 146 | 0.200 |
Why?
|
Self-Assessment | 2 | 2021 | 400 | 0.200 |
Why?
|
Vagina | 2 | 2018 | 849 | 0.200 |
Why?
|
Insurance | 1 | 2023 | 115 | 0.190 |
Why?
|
Cough | 2 | 2016 | 598 | 0.190 |
Why?
|
Anti-Anxiety Agents | 1 | 2024 | 405 | 0.190 |
Why?
|
Counseling | 4 | 2024 | 1554 | 0.190 |
Why?
|
Fetal Macrosomia | 1 | 2022 | 138 | 0.180 |
Why?
|
Tachycardia, Ventricular | 1 | 2010 | 1309 | 0.180 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2021 | 156 | 0.180 |
Why?
|
Peer Review, Research | 1 | 2024 | 344 | 0.180 |
Why?
|
Delivery Rooms | 1 | 2021 | 38 | 0.180 |
Why?
|
Markov Chains | 1 | 2024 | 979 | 0.180 |
Why?
|
Decision Making | 2 | 2024 | 3953 | 0.180 |
Why?
|
Patient Discharge | 2 | 2024 | 3491 | 0.180 |
Why?
|
Comorbidity | 5 | 2021 | 10592 | 0.170 |
Why?
|
Evidence-Based Practice | 2 | 2022 | 500 | 0.170 |
Why?
|
Self-Evaluation Programs | 1 | 2009 | 29 | 0.170 |
Why?
|
Pregnancy, Unplanned | 1 | 2021 | 86 | 0.170 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2011 | 125 | 0.170 |
Why?
|
Home Childbirth | 1 | 2020 | 55 | 0.170 |
Why?
|
Poverty | 3 | 2024 | 2720 | 0.170 |
Why?
|
Infant | 8 | 2024 | 36556 | 0.170 |
Why?
|
Pregnancy, High-Risk | 1 | 2020 | 121 | 0.170 |
Why?
|
Fetal Growth Retardation | 2 | 2022 | 592 | 0.170 |
Why?
|
Ghana | 2 | 2024 | 333 | 0.170 |
Why?
|
Ultrasonography | 4 | 2018 | 6002 | 0.160 |
Why?
|
Psychometrics | 2 | 2021 | 3066 | 0.160 |
Why?
|
Minority Health | 1 | 2020 | 79 | 0.160 |
Why?
|
Osteoblasts | 3 | 2010 | 1153 | 0.160 |
Why?
|
Intelligence | 1 | 2024 | 927 | 0.160 |
Why?
|
Decompression Sickness | 1 | 2019 | 16 | 0.160 |
Why?
|
Diving | 1 | 2019 | 43 | 0.160 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2019 | 2044 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2023 | 10400 | 0.160 |
Why?
|
Preconception Care | 1 | 2020 | 143 | 0.160 |
Why?
|
Medicaid | 3 | 2024 | 2843 | 0.160 |
Why?
|
Pregnancy Trimester, First | 2 | 2022 | 917 | 0.160 |
Why?
|
Anesthesia, Epidural | 1 | 2021 | 232 | 0.160 |
Why?
|
Oxytocin | 1 | 2023 | 403 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2024 | 718 | 0.160 |
Why?
|
Colposcopy | 2 | 2019 | 151 | 0.150 |
Why?
|
Time Factors | 6 | 2019 | 40261 | 0.150 |
Why?
|
Carcinoma | 1 | 2010 | 2340 | 0.150 |
Why?
|
Publishing | 2 | 2024 | 837 | 0.150 |
Why?
|
Umbilical Arteries | 1 | 2018 | 77 | 0.150 |
Why?
|
Heterosexuality | 1 | 2020 | 309 | 0.150 |
Why?
|
Laboratories | 1 | 2021 | 463 | 0.150 |
Why?
|
Coronary Artery Disease | 1 | 2017 | 6569 | 0.150 |
Why?
|
Adolescent | 10 | 2021 | 89244 | 0.140 |
Why?
|
Policy | 1 | 2021 | 514 | 0.140 |
Why?
|
Clinical Competence | 4 | 2015 | 4860 | 0.140 |
Why?
|
Injections, Intramuscular | 1 | 2018 | 556 | 0.140 |
Why?
|
Stem Cells | 1 | 2010 | 3539 | 0.140 |
Why?
|
Fournier Gangrene | 1 | 2017 | 22 | 0.140 |
Why?
|
Dilatation, Pathologic | 2 | 2020 | 527 | 0.140 |
Why?
|
Erythema Infectiosum | 1 | 2017 | 15 | 0.140 |
Why?
|
Research Design | 2 | 2024 | 6214 | 0.140 |
Why?
|
Centrioles | 1 | 2017 | 80 | 0.140 |
Why?
|
Body Mass Index | 4 | 2022 | 13055 | 0.140 |
Why?
|
Heroin | 1 | 2017 | 120 | 0.140 |
Why?
|
Aftercare | 1 | 2023 | 921 | 0.140 |
Why?
|
Hyperemesis Gravidarum | 1 | 2017 | 24 | 0.140 |
Why?
|
Vicia faba | 1 | 2016 | 5 | 0.140 |
Why?
|
Morocco | 1 | 2016 | 36 | 0.140 |
Why?
|
Prevalence | 3 | 2024 | 15879 | 0.140 |
Why?
|
Baclofen | 1 | 2017 | 120 | 0.140 |
Why?
|
Methimazole | 1 | 2016 | 41 | 0.140 |
Why?
|
Cytochrome-B(5) Reductase | 1 | 2016 | 17 | 0.140 |
Why?
|
Nicotine | 1 | 2022 | 680 | 0.140 |
Why?
|
Osmolar Concentration | 1 | 2017 | 657 | 0.140 |
Why?
|
Massachusetts | 3 | 2016 | 8894 | 0.140 |
Why?
|
Middle Aged | 19 | 2019 | 223737 | 0.140 |
Why?
|
Muscle Spasticity | 1 | 2017 | 159 | 0.130 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2017 | 173 | 0.130 |
Why?
|
Methemoglobinemia | 1 | 2016 | 45 | 0.130 |
Why?
|
Antithyroid Agents | 1 | 2016 | 72 | 0.130 |
Why?
|
AIDS Serodiagnosis | 1 | 2018 | 220 | 0.130 |
Why?
|
Ventricular Premature Complexes | 1 | 2017 | 112 | 0.130 |
Why?
|
Epidural Neoplasms | 1 | 2016 | 24 | 0.130 |
Why?
|
Infant, Premature | 2 | 2016 | 2123 | 0.130 |
Why?
|
Resuscitation | 1 | 2021 | 679 | 0.130 |
Why?
|
Methylene Blue | 1 | 2016 | 156 | 0.130 |
Why?
|
Clonazepam | 1 | 2016 | 135 | 0.130 |
Why?
|
Ear Canal | 1 | 2017 | 149 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 18068 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 2 | 2016 | 1892 | 0.130 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 1 | 2022 | 1988 | 0.130 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2024 | 954 | 0.130 |
Why?
|
Adoption | 1 | 2016 | 97 | 0.130 |
Why?
|
Resilience, Psychological | 1 | 2024 | 807 | 0.130 |
Why?
|
Hypophosphatemia | 1 | 2016 | 93 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 839 | 0.130 |
Why?
|
Piracetam | 1 | 2016 | 88 | 0.130 |
Why?
|
Decidua | 1 | 2015 | 82 | 0.120 |
Why?
|
Phenytoin | 1 | 2016 | 189 | 0.120 |
Why?
|
Meningitis | 1 | 2017 | 219 | 0.120 |
Why?
|
Gardening | 1 | 2015 | 18 | 0.120 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 2015 | 59 | 0.120 |
Why?
|
Health Services | 1 | 2020 | 755 | 0.120 |
Why?
|
Parental Consent | 1 | 2015 | 63 | 0.120 |
Why?
|
Laminectomy | 1 | 2016 | 226 | 0.120 |
Why?
|
Acyclovir | 1 | 2016 | 267 | 0.120 |
Why?
|
Antiemetics | 1 | 2017 | 188 | 0.120 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2017 | 264 | 0.120 |
Why?
|
Naloxone | 1 | 2017 | 372 | 0.120 |
Why?
|
Chorioamnionitis | 1 | 2016 | 156 | 0.120 |
Why?
|
Back Pain | 2 | 2017 | 548 | 0.120 |
Why?
|
Alcohol Drinking | 2 | 2018 | 4045 | 0.120 |
Why?
|
Marijuana Smoking | 1 | 2018 | 261 | 0.120 |
Why?
|
Pulmonary Edema | 1 | 2017 | 409 | 0.120 |
Why?
|
Propranolol | 1 | 2016 | 493 | 0.120 |
Why?
|
Oxycodone | 1 | 2016 | 144 | 0.120 |
Why?
|
Retinoblastoma Protein | 2 | 2008 | 673 | 0.120 |
Why?
|
Odds Ratio | 2 | 2018 | 9684 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2018 | 65480 | 0.120 |
Why?
|
Health Education | 1 | 2021 | 1059 | 0.120 |
Why?
|
Parasitemia | 1 | 2015 | 166 | 0.120 |
Why?
|
Retreatment | 1 | 2016 | 600 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 682 | 0.120 |
Why?
|
Alabama | 2 | 2024 | 112 | 0.120 |
Why?
|
Infant, Low Birth Weight | 1 | 2019 | 872 | 0.110 |
Why?
|
Intensive Care Units | 3 | 2016 | 3800 | 0.110 |
Why?
|
Hospitals, Urban | 2 | 2021 | 499 | 0.110 |
Why?
|
Fentanyl | 1 | 2017 | 450 | 0.110 |
Why?
|
Live Birth | 1 | 2018 | 516 | 0.110 |
Why?
|
Dopamine Agonists | 1 | 2017 | 347 | 0.110 |
Why?
|
Triazines | 1 | 2016 | 311 | 0.110 |
Why?
|
Maternal Exposure | 1 | 2021 | 1095 | 0.110 |
Why?
|
Pruritus | 1 | 2017 | 379 | 0.110 |
Why?
|
Vena Cava, Inferior | 1 | 2017 | 463 | 0.110 |
Why?
|
Gallbladder Diseases | 1 | 2005 | 139 | 0.110 |
Why?
|
Factor VIII | 1 | 2016 | 349 | 0.110 |
Why?
|
Hypotension | 2 | 2010 | 888 | 0.110 |
Why?
|
Unconsciousness | 1 | 2016 | 251 | 0.110 |
Why?
|
Residence Characteristics | 1 | 2024 | 2121 | 0.110 |
Why?
|
Outpatients | 1 | 2022 | 1603 | 0.110 |
Why?
|
Fluid Therapy | 1 | 2017 | 587 | 0.110 |
Why?
|
Ohio | 2 | 2024 | 321 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 2 | 2020 | 641 | 0.110 |
Why?
|
Reproducibility of Results | 3 | 2021 | 20245 | 0.110 |
Why?
|
Heparin | 1 | 2021 | 1636 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1216 | 0.110 |
Why?
|
Lyme Disease | 1 | 2019 | 630 | 0.110 |
Why?
|
Obesity | 3 | 2022 | 13091 | 0.110 |
Why?
|
Reproductive History | 1 | 2014 | 210 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 2016 | 658 | 0.110 |
Why?
|
Artemisinins | 1 | 2015 | 217 | 0.110 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2016 | 417 | 0.110 |
Why?
|
Cilia | 1 | 2017 | 498 | 0.110 |
Why?
|
Patient Admission | 2 | 2021 | 1370 | 0.110 |
Why?
|
Plasma | 1 | 2016 | 585 | 0.100 |
Why?
|
Adaptation, Psychological | 1 | 2024 | 2666 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2022 | 1520 | 0.100 |
Why?
|
Erythrocyte Count | 1 | 2013 | 157 | 0.100 |
Why?
|
Health Policy | 3 | 2021 | 2700 | 0.100 |
Why?
|
Fibrinogen | 1 | 2016 | 892 | 0.100 |
Why?
|
Cytoplasm | 1 | 2017 | 1505 | 0.100 |
Why?
|
Morbidity | 1 | 2018 | 1757 | 0.100 |
Why?
|
Viral Load | 2 | 2021 | 3398 | 0.100 |
Why?
|
Physical Examination | 2 | 2020 | 1262 | 0.100 |
Why?
|
Practice Guidelines as Topic | 4 | 2021 | 7460 | 0.100 |
Why?
|
Antidepressive Agents | 1 | 2024 | 2913 | 0.100 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 590 | 0.100 |
Why?
|
Drug Monitoring | 1 | 2018 | 965 | 0.100 |
Why?
|
Antimalarials | 2 | 2017 | 909 | 0.100 |
Why?
|
Urban Population | 1 | 2020 | 2046 | 0.100 |
Why?
|
Lower Extremity | 2 | 2017 | 1217 | 0.100 |
Why?
|
Placenta Accreta | 1 | 2015 | 242 | 0.100 |
Why?
|
Personality Inventory | 1 | 2014 | 1018 | 0.100 |
Why?
|
Family Planning Services | 2 | 2024 | 279 | 0.090 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 575 | 0.090 |
Why?
|
Double-Blind Method | 2 | 2023 | 12467 | 0.090 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2016 | 1243 | 0.090 |
Why?
|
HIV Seropositivity | 1 | 2016 | 967 | 0.090 |
Why?
|
Overweight | 1 | 2022 | 2448 | 0.090 |
Why?
|
Infusions, Intravenous | 2 | 2017 | 2231 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2017 | 3838 | 0.090 |
Why?
|
Organ Size | 1 | 2015 | 2268 | 0.090 |
Why?
|
Leiomyoma | 1 | 2015 | 644 | 0.090 |
Why?
|
Bone Matrix | 1 | 2010 | 127 | 0.080 |
Why?
|
Propofol | 1 | 2016 | 608 | 0.080 |
Why?
|
Child, Preschool | 3 | 2024 | 42683 | 0.080 |
Why?
|
Physician-Patient Relations | 2 | 2024 | 3269 | 0.080 |
Why?
|
Family | 2 | 2022 | 3208 | 0.080 |
Why?
|
Hospitals | 1 | 2023 | 3904 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2016 | 1119 | 0.080 |
Why?
|
Magnetic Resonance Imaging | 5 | 2018 | 36854 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2666 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3580 | 0.080 |
Why?
|
Cerebral Palsy | 1 | 2014 | 480 | 0.080 |
Why?
|
Program Evaluation | 1 | 2018 | 2508 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2024 | 3278 | 0.080 |
Why?
|
Hyperglycemia | 1 | 2017 | 1389 | 0.080 |
Why?
|
Insurance, Health | 2 | 2024 | 2518 | 0.080 |
Why?
|
Linear Models | 3 | 2020 | 5891 | 0.080 |
Why?
|
Area Under Curve | 1 | 2013 | 1645 | 0.080 |
Why?
|
Antioxidants | 1 | 2016 | 1673 | 0.080 |
Why?
|
Hypothermia | 1 | 2010 | 189 | 0.080 |
Why?
|
Reproduction | 1 | 2013 | 646 | 0.080 |
Why?
|
Cerebral Angiography | 1 | 2014 | 1272 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39394 | 0.080 |
Why?
|
Causality | 1 | 2014 | 1256 | 0.080 |
Why?
|
Bradycardia | 1 | 2010 | 305 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2055 | 0.080 |
Why?
|
Dexamethasone | 1 | 2016 | 1965 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2014 | 2360 | 0.080 |
Why?
|
Temporal Lobe | 1 | 2016 | 1728 | 0.070 |
Why?
|
Accidental Falls | 1 | 2016 | 1080 | 0.070 |
Why?
|
Probability | 1 | 2013 | 2483 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26395 | 0.070 |
Why?
|
New York | 1 | 2010 | 884 | 0.070 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 864 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2010 | 1755 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2018 | 1886 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2018 | 2784 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4879 | 0.070 |
Why?
|
Health Services Accessibility | 1 | 2024 | 5522 | 0.070 |
Why?
|
Time | 2 | 2019 | 552 | 0.070 |
Why?
|
Cartilage | 1 | 2010 | 811 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6526 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2023 | 5375 | 0.070 |
Why?
|
Mutation | 2 | 2010 | 30266 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2016 | 1924 | 0.070 |
Why?
|
Social Support | 1 | 2016 | 2193 | 0.060 |
Why?
|
Recurrence | 1 | 2018 | 8513 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2015 | 1424 | 0.060 |
Why?
|
Patient Satisfaction | 1 | 2018 | 3492 | 0.060 |
Why?
|
Heart Rate | 1 | 2017 | 4217 | 0.060 |
Why?
|
Regression Analysis | 1 | 2015 | 6346 | 0.060 |
Why?
|
Bone Development | 1 | 2008 | 473 | 0.060 |
Why?
|
Anticoagulants | 1 | 2021 | 4850 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6320 | 0.060 |
Why?
|
Fatal Outcome | 1 | 2010 | 1836 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3110 | 0.060 |
Why?
|
Bone Diseases | 1 | 2008 | 416 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2013 | 1163 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6236 | 0.060 |
Why?
|
Seizures | 1 | 2017 | 3000 | 0.060 |
Why?
|
Primary Health Care | 1 | 2020 | 4748 | 0.060 |
Why?
|
Pakistan | 1 | 2024 | 299 | 0.060 |
Why?
|
Brain Injuries | 1 | 2015 | 2058 | 0.060 |
Why?
|
Antiviral Agents | 1 | 2016 | 3070 | 0.050 |
Why?
|
Laparoscopy | 1 | 2015 | 2055 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12562 | 0.050 |
Why?
|
Insulin | 1 | 2017 | 6610 | 0.050 |
Why?
|
Hypoglycemia | 1 | 2010 | 895 | 0.050 |
Why?
|
Quality Improvement | 2 | 2017 | 3860 | 0.050 |
Why?
|
Osteosarcoma | 1 | 2008 | 911 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20776 | 0.050 |
Why?
|
Aged | 7 | 2019 | 171786 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4862 | 0.050 |
Why?
|
Kenya | 1 | 2024 | 758 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2016 | 4530 | 0.050 |
Why?
|
Brazil | 1 | 2024 | 1250 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2024 | 646 | 0.040 |
Why?
|
HIV-1 | 1 | 2018 | 6962 | 0.040 |
Why?
|
Models, Statistical | 1 | 2015 | 5110 | 0.040 |
Why?
|
California | 1 | 2024 | 1443 | 0.040 |
Why?
|
Electroencephalography | 1 | 2016 | 6317 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2015 | 4339 | 0.040 |
Why?
|
Ticks | 1 | 2019 | 71 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2016 | 4423 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 769 | 0.040 |
Why?
|
Cell Lineage | 1 | 2008 | 2576 | 0.040 |
Why?
|
Vermont | 1 | 2019 | 80 | 0.040 |
Why?
|
Lung | 1 | 2017 | 10099 | 0.040 |
Why?
|
Thinness | 1 | 2022 | 483 | 0.040 |
Why?
|
Goals | 1 | 2024 | 717 | 0.040 |
Why?
|
Online Systems | 1 | 2009 | 182 | 0.040 |
Why?
|
Term Birth | 1 | 2019 | 140 | 0.040 |
Why?
|
Antibody Formation | 1 | 2023 | 1393 | 0.040 |
Why?
|
After-Hours Care | 1 | 2019 | 102 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 494 | 0.040 |
Why?
|
Hyperbaric Oxygenation | 1 | 2019 | 166 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2960 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2022 | 753 | 0.040 |
Why?
|
Prevotella melaninogenica | 1 | 2017 | 13 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2010 | 10486 | 0.040 |
Why?
|
Referral and Consultation | 2 | 2023 | 3628 | 0.040 |
Why?
|
Quinine | 1 | 2017 | 51 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2022 | 749 | 0.030 |
Why?
|
Paraplegia | 1 | 2017 | 161 | 0.030 |
Why?
|
Consensus | 2 | 2017 | 3214 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2019 | 260 | 0.030 |
Why?
|
Curriculum | 1 | 2010 | 3782 | 0.030 |
Why?
|
Injections, Spinal | 1 | 2017 | 318 | 0.030 |
Why?
|
Heroin Dependence | 1 | 2017 | 173 | 0.030 |
Why?
|
Groin | 1 | 2017 | 106 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2024 | 2744 | 0.030 |
Why?
|
Clindamycin | 1 | 2017 | 138 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15661 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2017 | 59739 | 0.030 |
Why?
|
Housing | 1 | 2021 | 683 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2017 | 432 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 2017 | 297 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2019 | 916 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.030 |
Why?
|
Mood Disorders | 1 | 2022 | 1129 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8559 | 0.030 |
Why?
|
Doxycycline | 1 | 2017 | 349 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2017 | 574 | 0.030 |
Why?
|
Otitis Media | 1 | 2017 | 288 | 0.030 |
Why?
|
Labor, Obstetric | 1 | 2018 | 323 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14201 | 0.030 |
Why?
|
Shock | 1 | 2017 | 316 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9213 | 0.030 |
Why?
|
Debridement | 1 | 2017 | 494 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2008 | 11684 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 30046 | 0.030 |
Why?
|
Dyspnea | 1 | 2011 | 1352 | 0.030 |
Why?
|
Blood Component Transfusion | 1 | 2014 | 141 | 0.030 |
Why?
|
Quality of Life | 1 | 2015 | 13510 | 0.030 |
Why?
|
Drug Interactions | 1 | 2018 | 1418 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2017 | 530 | 0.030 |
Why?
|
Autoantigens | 1 | 2017 | 891 | 0.030 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1470 | 0.030 |
Why?
|
Insurance Coverage | 1 | 2024 | 1946 | 0.030 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2017 | 628 | 0.030 |
Why?
|
Diarrhea | 1 | 2019 | 1320 | 0.030 |
Why?
|
Exanthema | 1 | 2017 | 503 | 0.020 |
Why?
|
Teaching | 1 | 2009 | 1171 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15889 | 0.020 |
Why?
|
Lactic Acid | 1 | 2017 | 1140 | 0.020 |
Why?
|
Propensity Score | 1 | 2019 | 1968 | 0.020 |
Why?
|
Social Perception | 1 | 2015 | 433 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12253 | 0.020 |
Why?
|
Radiography, Thoracic | 1 | 2017 | 1321 | 0.020 |
Why?
|
Mothers | 1 | 2021 | 2209 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4568 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8748 | 0.020 |
Why?
|
Inpatients | 1 | 2022 | 2569 | 0.020 |
Why?
|
Medical Records | 1 | 2016 | 1411 | 0.020 |
Why?
|
Animals | 5 | 2019 | 169335 | 0.020 |
Why?
|
Coronary Angiography | 1 | 2011 | 4541 | 0.020 |
Why?
|
Continuity of Patient Care | 1 | 2017 | 1076 | 0.020 |
Why?
|
Echocardiography | 1 | 2011 | 5047 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 11886 | 0.020 |
Why?
|
Heart Diseases | 1 | 2011 | 2819 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2784 | 0.020 |
Why?
|
Mice | 3 | 2010 | 82072 | 0.020 |
Why?
|
E2F1 Transcription Factor | 1 | 2008 | 182 | 0.020 |
Why?
|
Antigens, Ly | 1 | 2008 | 296 | 0.020 |
Why?
|
Checklist | 1 | 2014 | 841 | 0.020 |
Why?
|
Integrases | 1 | 2008 | 520 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3450 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14794 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3709 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3238 | 0.010 |
Why?
|
Smoking | 1 | 2021 | 9094 | 0.010 |
Why?
|
Public Health | 1 | 2018 | 2680 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2018 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2474 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7609 | 0.010 |
Why?
|
Mice, Nude | 1 | 2008 | 3631 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4592 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2016 | 4544 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2008 | 6131 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2008 | 1356 | 0.010 |
Why?
|
Cell Cycle | 1 | 2008 | 2937 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22379 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2008 | 2848 | 0.010 |
Why?
|
Internship and Residency | 1 | 2019 | 5956 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21547 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2008 | 4926 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 3612 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2008 | 9565 | 0.010 |
Why?
|
Brain | 1 | 2021 | 27453 | 0.010 |
Why?
|
Genotype | 1 | 2008 | 13048 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12806 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2008 | 14484 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2008 | 7885 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2008 | 18354 | 0.000 |
Why?
|